SHSE:688136 (China)
Â
Class A
Â¥
21.22
-0.21 (-0.98%)
Jul 12
Business Description
Shan Dong Kexing Bioproducts Co Ltd
ISIN : CNE100006ZG6
Share Class Description:
SHSE:688136: Class ATotal Employee Number:
1,048Compare
Compare
Traded in other countries / regions
688136.China Index Membership
SSE Composite Index IPO Date
2020-12-14Description
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.45 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.82 | |||||
Debt-to-EBITDA | 9.4 | |||||
Interest Coverage | 1.36 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.31 | |||||
Beneish M-Score | -2.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.9 | |||||
3-Year Book Growth Rate | -1.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 63.05 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.42 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.97 | |||||
9-Day RSI | 56.54 | |||||
14-Day RSI | 53.31 | |||||
3-1 Month Momentum % | -38.24 | |||||
6-1 Month Momentum % | -46.53 | |||||
12-1 Month Momentum % | -59.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.5 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 0.61 | |||||
Days Inventory | 87.23 | |||||
Days Sales Outstanding | 143.06 | |||||
Days Payable | 127.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.18 | |||||
Dividend Payout Ratio | 0.32 | |||||
3-Year Dividend Growth Rate | -7.2 | |||||
Forward Dividend Yield % | 1.18 | |||||
5-Year Yield-on-Cost % | 1.18 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -2.95 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.37 | |||||
Operating Margin % | 3.9 | |||||
Net Margin % | 7.67 | |||||
EBITDA Margin % | 10.27 | |||||
FCF Margin % | -1.44 | |||||
OCF Margin % | 4.62 | |||||
ROE % | 6.56 | |||||
ROA % | 3.31 | |||||
ROIC % | 2.18 | |||||
3-Year ROIIC % | 31.58 | |||||
ROC (Joel Greenblatt) % | 9.51 | |||||
ROCE % | 6.22 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.89 | |||||
Forward PE Ratio | 23.06 | |||||
PE Ratio without NRI | 85.22 | |||||
PS Ratio | 2.9 | |||||
PB Ratio | 2.47 | |||||
Price-to-Tangible-Book | 3.04 | |||||
Price-to-Operating-Cash-Flow | 58.78 | |||||
EV-to-EBIT | 33.7 | |||||
EV-to-EBITDA | 33.7 | |||||
EV-to-Revenue | 3.46 | |||||
EV-to-FCF | -240.19 | |||||
Price-to-GF-Value | 0.89 | |||||
Price-to-Graham-Number | 3.42 | |||||
Earnings Yield (Greenblatt) % | 2.97 | |||||
FCF Yield % | -0.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shan Dong Kexing Bioproducts Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,460.993 | ||
| EPS (TTM) (Â¥) | 0.56 | ||
| Beta | 0.6458 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.5 | ||
| Volatility % | 54.75 | ||
| 14-Day RSI | 53.31 | ||
| 14-Day ATR (Â¥) | 1.640525 | ||
| 20-Day SMA (Â¥) | 19.916 | ||
| 12-1 Month Momentum % | -59.72 | ||
| 52-Week Range (Â¥) | 17.18 - 58 | ||
| Shares Outstanding (Mil) | 201.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shan Dong Kexing Bioproducts Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shan Dong Kexing Bioproducts Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.250000 Cash Dividend | 2026-06-15 | 19.08 (+1.44%) | ||
| CNY 0.080000 Cash Dividend | 2025-06-12 | 51.54 (-7.30%) |
Show
Entries
Shan Dong Kexing Bioproducts Co Ltd Frequently Asked Questions
What is Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136)'s stock price today?
The current price of SHSE:688136 is ¥21.22. The 52 week high of SHSE:688136 is ¥58.00 and 52 week low is ¥17.18.
When is next earnings date of Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136)?
The next earnings date of Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136) is .
Does Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136) pay dividends? If so, how much?
The Dividend Yield %  of Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136) is 1.18% (As of Today), Highest Dividend Payout Ratio of Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136) was 0.33. The lowest was 0.29. And the median was 0.31. The  Forward Dividend Yield % of Shan Dong Kexing Bioproducts Co Ltd(SHSE:688136) is 1.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Shan Dong Kexing Bioproducts Co Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers